A drug formulation that releases the active ingredient at a steady rate. This can be done by a variety of technologies, including liposomes, subcutaneous injections of a polymer matrix, and transdermal patches. Controlled release of a drug can increase patient comfort and compliance by reducing the number of injections or oral doses that must be taken, as well as avoiding the "peak and valley" profile of drug concentration in the blood that is usually seen after a dose of conventional formulations.
Glossary
Controlled Release Formula
02.27.12
-
Drug Development
Solving the Pharma Talent Crunch
Addressing talent shortages in today's pharmaceutical sectorJim Sykes, Managing Director, Pharmaceutical & Life Sciences, Alexander Mann Solutions
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE, Selecta Biosciences Form Mfg. Pact
LSNE to provide drug substance manufacturing and fill/finish services
-
Breaking News | Drug Development | Industry News | Preclinical Outsourcing
Pierre Fabre Buys Igenica Immuno-oncology Assets
Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis SA and OSE Immunotherapeutics Enter Pact
Sign agreement for the development of OSE's interleukin receptor 7 antagonist
